Food Vaccines Show Promise Now Forget about Them

The lack of refrigeration remains a vexing problem in vaccinating the world's poor, because drugs often lose their efficacy in the heat. One solution 200 years ago was to propagate the vaccine in orphan children. "It was a really fascinating idea," remarks Charles Arntzen, founder of the Biodesign Institute at Arizona State University but not one to be implemented today. Instead Arntzen has hopes for vaccines that exist inside crops and could just be eaten.

Arntzen conceived the idea of edible vaccines in the 1990s and has since tried to realize it. He genetically engineered potatoes to produce a vaccine against the hepatitis B virus, which kills one million people every year. This past February he reported that in a trial of an edible vaccine, up to 60 percent of volunteers who ate raw chunks of the potato developed antibodies against the virus. The signs of immunity are "an excellent start," Arntzen says.

Even so, Arntzen and others in the field are abandoning food vaccines. Consumer fear that the modified fruits and vegetables could end up in grocery stores is one issue. The medical worry, though, is the dosage: as public health expert Jurrien Toonen of the Royal Tropical Institute in Amsterdam points out, a tomato or banana is never the same size, so the quantity of the vaccine could vary from one piece to the next.

Because of the dosage concern, Hilary Koprowski of Thomas Jefferson University, the discoverer of the live polio vaccine, discounts the use of raw plants for massive immunization, even for farm animals. "The edible vaccine should be given in capsules containing desiccated leaf extract," he says.

Others agree that shifting the strategy for edible vaccines from food to processed pills makes sense. Achieving uniform doses would be easier, whether the extracts come from potatoes, lettuce, corn or even tobacco leaves (if the nicotine and other alkaloids could be removed). "We can freeze and dry potato, pack it in gelatin capsules and make uniform dosages of the vaccine," Arntzen notes. And pills would be cheaper. The Biodesign Institute projects that 200 acres would produce enough hepatitis B antigen to immunize all the babies in the world, at a cost of $0.05 per dose, compared with $0.30, the lowest price of the current vaccine. Trials for edible vaccine pills will probably begin in four to five years.

"Edible vaccines offer great advantages, as they do not need cold for conservation," Toonen says. "But they are not enough to resolve the whole situation." Even if they prove their efficacy, he states, they would face the logistical problems of some countries that make it difficult to deliver even the simplest pharmaceuticals to places far from urban centers, where most children are vaccinated. And Arntzen is aware of groups that systematically oppose genetic engineering. But he is optimistic: "It is going to be hard to justify blocking genetically modified plants if we can document we are reducing infant mortality.

The Straight Dope on Cannabis-Inspired Meds

While the medical marijuana debate rages on, drug companies race to leverage the power of pot

Last spring Canada became the first and only country to approve a drug called Sativex to treat the chronic pain endured by most of the 2.5 million people with multiple sclerosis. The announcement caused, ahem, quite a buzz. Sativex is a whole-plant extract of high-grade Cannabis sativa, a.k.a. marijuana, and is the first prescription drug to contain all 60-plus of the plant's cannabinoids, those compounds that include the psychoactive chemical THC. Although the drug packs a pain-numbing punch, its mouth-spray formulation slows its release into the body, thus diminishing those consciousness-altering side effects associated with smoking marijuana.

Despite a U.S. Supreme Court decision in June to uphold the ban on medical marijuana, drug companies are not discouraged. In fact, Sativex is just one of nearly two dozen new pharmaceutical compounds inspired by the herb. Last year the Society for Neuroscience conference featured almost 200 papers on cannabinoids; a decade ago there were exactly zero. And 22 pharmaceutical companies, including giants Pfizer and GlaxoSmith-Kline, helped fund last year's meeting of the International Cannabinoid Research Society. In 1992 not a single drug company attended, according to executive director Richard Musty. "Now," he says, "they're showing up and madly taking notes."

The newfound interest stems from a flurry of discoveries in the early 1990s that showed that the body is littered with cannabinoid receptors. In fact, we have more of them in the brain than most other types, which may explain why they regulate such a vast array of functions-appetite, pain, memory, mood. Luckily for us, such multitasking paves the way for drugs to treat everything from obesity and migraines to cancer and Parkinson's disease. Below, a small sampling of the goods.

Similar of Food Vaccines Show Promise Now Forget about Them

WHO: Government Complacency, Funding Shortfalls Contributed to Indonesia's Polio Outbreak

September 12 2005 Government complacency and a funding drop fueled a recent polio outbreak that has sickened 225 people in Indonesia and raised fears of an

Prostate Cancer Vaccine Shows Promise

Prostate Cancer Vaccine Shows Promise An experimental vaccine has extended the lives of men with advanced prostate cancer in a clinical trial, according to the therapy's developer, Dendreon. The

Scientific Breakthrough in Malaria Vaccine Development

Scientific Breakthrough in Malaria Vaccine Development Researchers report that GSK Biologicals' RTS.S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria.

Measles, Mumps and Rubella Vaccines (MMR)

Adverse Events After MMR Vaccination Adverse events associated with administration of MMR vaccine range from local pain, induration, and edema to rare systemic

The Brain's Own Marijuana

Research into natural chemicals that mimic marijuana's effects in the brain could help to explain--and suggest treatments for--pain, anxiety, eating disorders

Are You Eating Genetically Engineered (GE) Foods?

Are You Eating Genetically Engineered (GE) Foods? If you are concerned about genetically engineered foods in your shopping cart, you better act now! Here are some things you should know before you buy any food

Drug Puzzle: When Do Risks Outweigh Benefits?

In one of the great examples of the mixed messages of science, the same study that killed the blockbuster arthritis drug Vioxx after showing that it had heart



Post new comment